Core Viewpoint - 惠理集团 reported a strong performance for the six months ending June 30, 2025, with significant profit growth despite a decline in total revenue [1] Financial Performance - Total revenue for the period was HKD 221 million, a decrease of 6.3% year-on-year [1] - Profit attributable to shareholders reached HKD 252 million, an increase of 572.7% year-on-year [1] - Basic earnings per share were HKD 0.138 [1] Investment and Fundraising - The strong performance was primarily driven by investment income from proprietary funds, which offset a slight decline in management fees [1] - Fundraising maintained growth momentum, with total subscriptions reaching USD 733 million in the first half of 2025 [1] - Notably, there was strong inflow into focus funds in mainland China, and high demand for the company's USD money market fund [1] Financial Position - As of June 30, 2025, the group maintained a robust balance sheet with a net asset value of HKD 3.8 billion [1] - This includes cash and cash equivalents of HKD 1.5 billion and investments totaling HKD 2.3 billion [1] - The company continues to uphold prudent financial management to ensure strategic flexibility and resilience for long-term growth [1]

Core Viewpoint - 惠理集团 reported a strong performance for the six months ending June 30, 2025, with significant profit growth driven by investment returns, despite a decline in total revenue [1] Financial Performance - Total revenue for the period was HKD 221 million, a year-on-year decrease of 6.3% [1] - Profit attributable to owners was HKD 252 million, reflecting a year-on-year increase of 572.7% [1] - Basic earnings per share were HKD 0.138 [1] Investment and Fundraising - The strong performance was primarily attributed to investment returns from proprietary funds, which offset a slight decline in management fees [1] - Total subscriptions for the first half of 2025 reached USD 733 million, indicating continued growth in fundraising [1] - Notably, there was strong inflow into focus funds in mainland China, and high demand for the company's USD money market fund [1] Financial Position - As of June 30, 2025, the group maintained a robust balance sheet with a net asset value of HKD 3.8 billion [1] - This includes cash and cash equivalents of HKD 1.5 billion and investments totaling HKD 2.3 billion [1] - The company continues to uphold prudent financial management to ensure strategic flexibility and resilience for long-term growth [1]

Core Viewpoint - 惠理集团 reported a strong performance for the six months ending June 30, 2025, with significant profit growth driven by investment returns, despite a slight decline in management fees [1] Financial Performance - Total revenue for the period was HKD 221 million, a year-on-year decrease of 6.3% [1] - Profit attributable to shareholders reached HKD 252 million, marking a year-on-year increase of 572.7% [1] - Basic earnings per share were HKD 0.138 [1] Investment and Fundraising - The company maintained a strong fundraising momentum in the first half of 2025, with total subscriptions amounting to USD 733 million [1] - Notably, there was strong inflow into focus funds from mainland China, and high demand for the 惠理美元货币基金 [1] - Increasing investor interest in the company's income-oriented strategies, such as the 惠理亚洲股债收益基金, was observed [1] Balance Sheet and Financial Management - As of June 30, 2025, the group maintained a robust balance sheet with a net asset value of HKD 3.8 billion [1] - This includes cash and cash equivalents of HKD 1.5 billion and investments totaling HKD 2.3 billion [1] - The company continues to uphold prudent financial management to ensure strategic flexibility and resilience for long-term growth [1]

Core Viewpoint - 惠理集团 reported a significant increase in profit despite a decline in total revenue, indicating strong performance in investment activities [1] Financial Performance - Total revenue for the six months ended June 30, 2025, was HKD 221 million, a decrease of 6.3% year-on-year [1] - Profit attributable to owners surged to HKD 252 million, reflecting a substantial increase of 572.7% year-on-year [1] - Basic earnings per share were HKD 0.138 [1] Investment and Fundraising - The strong performance was primarily driven by returns from proprietary investments, which offset a slight decline in management fees [1] - Total subscriptions for the first half of 2025 reached USD 733 million, with notable performance from mainland China-focused funds and the 惠理 USD Money Market Fund [1] - The income-oriented strategy attracted more investors [1] Asset Management - As of June 30, 2025, the group's net asset value stood at HKD 3.8 billion, comprising HKD 1.5 billion in cash and cash equivalents, and HKD 2.3 billion in investments [1]

Core Viewpoint - 惠理集团 reported a total revenue of HKD 221 million for the six months ending June 30, 2025, representing a year-on-year decline of 6.3%, while the profit attributable to shareholders surged to HKD 252 million, a significant increase of 572.7% [1] Financial Performance - Total revenue for the period was HKD 221 million, down 6.3% year-on-year [1] - Profit attributable to shareholders reached HKD 252 million, up 572.7% year-on-year [1] - Basic earnings per share were HKD 0.138 [1] Investment Performance - Strong performance was primarily driven by investment income from proprietary funds, which offset a slight decline in management fees [1] - The total subscription amount for fundraising in the first half of 2025 was USD 733 million [1] - Notably, the mainland China-focused funds experienced strong inflows, and there was significant demand for the 惠理美元货币基金 [1] Asset Management - As of June 30, 2025, the group maintained a robust balance sheet with a net asset value of HKD 3.8 billion [1] - This includes cash and cash equivalents of HKD 1.5 billion and investments totaling HKD 2.3 billion [1] - The group continues to uphold prudent financial management to ensure strategic flexibility and resilience for long-term growth [1]

Core Viewpoint - 惠理集团 reported a total revenue of HKD 221 million for the six months ending June 30, 2025, representing a year-on-year decline of 6.3%, while profit attributable to shareholders surged to HKD 252 million, a significant increase of 572.7% [1] Financial Performance - Total revenue for the period was HKD 221 million, down 6.3% year-on-year [1] - Profit attributable to shareholders reached HKD 252 million, up 572.7% year-on-year [1] - Basic earnings per share were HKD 0.138 [1] Investment Performance - Strong performance was primarily driven by investment income from proprietary funds, which offset a slight decline in management fees [1] - The total subscription amount for fundraising in the first half of 2025 was USD 733 million [1] - Notably, the mainland China-focused funds experienced strong inflows, and there was significant demand for the 惠理美元货币基金 [1] Asset Management - As of June 30, 2025, the group maintained a robust balance sheet with a net asset value of HKD 3.8 billion [1] - This includes cash and cash equivalents of HKD 1.5 billion and investments totaling HKD 2.3 billion [1] - The group continues to adhere to prudent financial management, ensuring strategic flexibility and resilience for long-term growth [1]

Group 1 - The core viewpoint of the article is that 惠理集团 (Hui Li Group) reported a decrease in total revenue but a significant increase in net profit for the period ending June 30, 2025 [1] Group 2 - The total revenue for 惠理集团 was HKD 221 million, representing a year-on-year decrease of 6.3% [1] - The company recorded a net profit of HKD 252 million, a substantial increase from HKD 37 million in the same period last year [1] - The strong performance was primarily driven by investment income from proprietary funds, which offset a slight decline in management fees [1]

Financial Performance - Total revenue for the six months ended June 30, 2025, was HKD 220.8 million, a decrease of 6.3% compared to HKD 235.7 million in 2024[2] - Total management fees decreased by 7.6% to HKD 185.6 million from HKD 200.8 million in the previous year[2] - Performance fees dropped significantly by 40.2% to HKD 5.8 million from HKD 9.7 million[2] - The company reported an operating loss of HKD 19.7 million, a decline of 3,383.3% compared to an operating profit of HKD 0.6 million in 2024[2] - Profit attributable to owners of the company surged by 572.7% to HKD 251.6 million from HKD 37.4 million[2] - Basic and diluted earnings per share increased by 590.0% to HKD 13.8 from HKD 2.0[2] - Net income for the period was HKD 251.6 million, compared to HKD 37.4 million in the previous year[4] - Total comprehensive income for the period was HKD 281.0 million, up from HKD 28.4 million in 2024[4] - The financial results indicate a strong recovery in profitability despite a decline in revenue and management fees[3] Assets and Investments - Non-current assets totaled HKD 2,427,321,000 as of June 30, 2025, slightly down from HKD 2,538,300,000 at the end of 2024[5] - Cash and cash equivalents increased to HKD 1,524,960,000 from HKD 1,077,437,000, marking a growth of 41.5%[5] - The total equity attributable to owners increased to HKD 3,814,780,000 from HKD 3,552,063,000, reflecting a growth of 7.4%[5] - As of June 30, 2025, the investment in joint ventures amounted to HKD 555.9 million, an increase from HKD 479.7 million as of December 31, 2024, representing a growth of approximately 15.5%[16] - The total investment amount as of June 30, 2025, was HKD 1,321.5 million, compared to HKD 1,749.1 million as of December 31, 2024, reflecting a decrease of approximately 24.5%[19] - The amount invested in associates was HKD 334 million as of June 30, 2025, down from HKD 568 million as of December 31, 2024, indicating a reduction of approximately 41.3%[20] Dividends and Shareholder Returns - The company did not declare an interim dividend for the period[2] - The company declared a final dividend of HKD 18,267,000 for the year ended December 31, 2024, with no interim dividend proposed for the six months ended June 30, 2025[14] Operational Highlights - The company is actively developing new products to capture emerging opportunities in the market, particularly in AI, blockchain, and virtual assets[29] - The company has strengthened its customer interactions and expanded distribution channels through various cross-border initiatives, enhancing its role as a connector between mainland China and international markets[32] - The company is applying for MRF mutual recognition qualifications for multi-asset and fixed-income strategy products to expand its distribution in the mainland retail market[33] - The company continues to collaborate with domestic institutions to develop customized investment solutions, enhancing its product offerings for both institutional and retail clients[34] Fund Performance - The flagship product, the high-dividend stock fund, attracted significant capital inflows, reflecting investor confidence in the company's income-oriented strategies[33] - The flagship product, the High Yield Equity Fund, achieved a year-to-date return of 14.5%, reaching a historical high, demonstrating the ability to generate sustainable income and capital appreciation through a diversified Asian high-yield equity portfolio[39] - The Asia Income Series Fund recorded a year-to-date return of 10.7%, ranking in the top 25% among similar funds as of June 30, 2025[39] - The China Focus Fund achieved a year-to-date return of 13.9%, reflecting investor confidence in the company's local expertise, with net inflows recorded[40] - The Value Gold ETF delivered an impressive year-to-date return of 26.6%, solidifying its reputation as one of the top products in the region[41] Strategic Initiatives - The company is actively seeking to expand its ETF product lineup, focusing on innovative products related to tokenization and virtual assets, as well as diversified asset classes including gold[43] - The company has successfully invested in several innovative medical enterprises, including a $123 million Series E funding round for a company focused on AI-driven drug development[42] - The company is enhancing its core investment capabilities, optimizing coverage of equities and fixed income in the Asia-Pacific region, and exploring global asset opportunities[44] - The company has established strategic partnerships in Southeast Asia, including Singapore and Malaysia, to capture growth in the region and enhance service diversification[36] - The company is advancing its private equity business, focusing on high-potential areas such as artificial intelligence and biotechnology[37] Corporate Governance - The company established an audit committee consisting of three independent non-executive directors to comply with the listing rules of the Hong Kong Stock Exchange[82] - The interim results for the six months ending June 30, 2025, have been reviewed by the external auditor in accordance with Hong Kong Review Standards[83] - The company is committed to maintaining high standards of corporate governance and has adhered to the corporate governance code as of June 30, 2025[84] - All directors confirmed compliance with the standard code for securities transactions as of June 30, 2025[85] Employee and Cost Management - The group employed 106 staff in Hong Kong as of June 30, 2025, down from 125 a year earlier, and maintained a competitive compensation structure to reward employee contributions[80] - The group continues to adopt a cautious approach to cost management while investing in key strategic growth areas to enhance competitive advantage[72] - The group has implemented resource adjustments and ongoing cost control measures to address future business challenges[72]

Group 1 - Recent data indicates a surge in international capital reallocating towards Chinese assets, with nearly 60% of sovereign wealth funds prioritizing China as an investment market [1][2] - Korean investors have shown increasing enthusiasm for Chinese stocks, with a cumulative trading volume of $5.764 billion in 2023, making China the second-largest overseas investment destination for Korean investors [2] - UBS's survey reveals that 19% of global family offices plan to increase their allocation to Chinese assets, marking a 3 percentage point increase from 2024 [2] Group 2 - In July, five major overseas Chinese stock ETFs attracted over $2 billion in investments, with significant growth in assets under management for several ETFs [3] - Sovereign wealth funds are driven to allocate to Chinese assets due to attractive local returns, diversification benefits, and expanded market access for foreign investors [3] Group 3 - The Chinese economy's recovery has exceeded market expectations, bolstered by rapid policy responses to stabilize expectations and stimulate growth, enhancing international investor confidence [4] - China has made significant advancements in technology and innovation, leading to a re-evaluation of asset valuations by international investors [4] Group 4 - As of August 1, four A-share stocks have over 24% foreign ownership, indicating strong foreign interest in companies with global competitiveness [5] - Foreign investors are selectively investing in growth stocks, focusing on companies with sustainable performance and expanding market shares [6] Group 5 - Foreign capital is favoring high-dividend stocks and growth stocks, reflecting a dual strategy of defense and offense in investment [7] - High-dividend stocks are recognized for their stable cash flows and strong governance, while growth stocks represent long-term bets on China's economic transformation [8]

致：香港交易及結算所有限公司 公司名稱: 惠理集團有限公司 (於開曼群島註冊成立之有限責任公司) 呈交日期: 2025年8月1日 I. 法定/註冊股本變動 FF301 截至月份: 2025年7月31日 狀態: 新提交 股份發行人及根據《上市規則》第十九B章上市的香港預託證券發行人的證券變動月報表 | 1. 股份分類 | 普通股 | 股份類別 | 不適用 | | 於香港聯交所上市 (註1) | 是 | | | --- | --- | --- | --- | --- | --- | --- | --- | | 證券代號 (如上市) | 00806 | 說明 | | | | | | | | | 已發行股份（不包括庫存股份）數目 | | 庫存股份數目 | | 已發行股份總數 | | | 上月底結存 | | | 1,826,709,831 | | 0 | | 1,826,709,831 | | 增加 / 減少 (-) | | | 0 | | 0 | | | | 本月底結存 | | | 1,826,709,831 | | 0 | | 1,826,709,831 | 第 2 頁 共 10 頁 v 1.1.1 | 1. 股份 ...